Abstract
This paper, for the first time, demonstrates that exposure of cells to the poly(ethylene oxide)-poly(propylene oxide) block copolymer, Pluronic P85, results in a substantial decrease in ATP levels selectively in MDR cells. Cells expressing high levels of functional P-glycoprotein (MCF-7/ADR, KBv; LLC-MDR1; Caco-2, bovine brain microvessel endothelial cells [BBMECs]) are highly responsive to Pluronic treatment, while cells with low levels of P-glycoprotein expression (MCF-7, KB, LLC-PK1, human umbilical vein endothelial cells [HUVECs] C2C12 myoblasts) are much less responsive to such treatment. Cytotoxicity studies suggest that Pluronic acts as a chemosensitizer and potentiates cytotoxic effects of doxorubicin in MDR cells. The ability of Pluronic to inhibit P-glycoprotein and sensitize MDR cells appears to be a result of ATP depletion. Because many mechanisms of drug resistance are energy dependent, a successful strategy for treating MDR cancer could be based on selective energy depletion in MDR cells. Therefore, the finding of the energy-depleting effects of Pluronic P85, in combination with its sensitization effects is of considerable theoretical and practical significance. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Alakhov VYu, Moskaleva EYu, Batrakova EV and Kabanov AV (1996) Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer. Bioconjug Chem 7: 209–216
Alakhov V, Klinsky E, Li S, Pietrzynski G, Venne A, Batrakova E, Bronich T and Kabanov A (1999) Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials. Colloids and Surfaces B: Biointerfaces 16: 113–134
Altan N, Chen Y, Schindler M and Simon SM (1998) Defective acidification in human breast tumor cells and implications for chemotherapy. J Exp Med 187: 1583–1598
Batrakova EV, Dorodnych TY, Klinskii EY, Kliushnenkova EN, Shemchukova OB, Goncharova ON, Arjakov SA, Alakhov VY and Kabanov AV (1996) Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity. Br J Cancer 74: 1545–1552
Batrakova EV, Han HY, Miller DW and Kabanov AV (1998) Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells. Pharm Res 15: 1525–1532
Batrakova E, Lee S, Li S, Venne A, Alakhov V and Kabanov A (1999) Fundamental relationships between the composition of Pluronic block copolymers and their hypersensitization effect in MDR cancer cells. Pharm Res 16: 1375–1381
Batrakova EV, Miller DW, Li S, Alakhov VY, Kabanov AV and Elmquist WF (2001) Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. J Pharmacol Exp Ther 296: 551
Benderra Z, Morjani H, Trussardi A and Manfait M (1998) Role of the vacuolar H+-ATPase in daunorubicin distribution in etoposide-resistant MCF7 cells overexpressing the multidrug-resistance associated protein. Int J Oncol 12: 711–715
Druekes P, Schinzel R and Palm D (1995) Photometric microtiter assay of inorganic phosphate in the presence of acid-labile organic phosphates. Analytical Biochem 230: 173–177
Evers R, Zaman GJ, van Deemter L, Jansen H, Calafat J, Oomen LC, Oude Elferink RP, Borst P and Schinkel AH (1996) Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. J Clin Invest 97: 1211–1218
Evers R, Kool M, van Deemter L, Janssen H, Calafat J, Oomen LC, Paulusma CC, Oude Elferink RP, Baas F, Schinkel AH and Borst P (1998) Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J Clin Invest 101: 1310–1319
Evers R, Kool M, Smith AJ, van Deemter L, de Haas M and Borst P (2000) Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport. Br J Cancer 83: 366–374
Ferrari M, Fornasiero MC and Isetta AM (1990) MTT colorimetric assay for testing macrophage cytotoxic activity in vitro. J Immunol Methods 131: 165–172
Fontaine M, Elmquist WF and Miller DW (1996) Use of rhodamine 123 to examine the functional activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayers. Life Sci 59: 1521–1531
Garewal HS, Ahmann FR, Schifman RB and Celniker A (1986) ATP assay: ability to distinguish cytostatic from cytocidal anticancer drug effects. J Natl Cancer Inst 77: 1039–1045
Goldstein LJ, Gottesman MM and Pastan I (1992) Multidrug resistance in human cancers. Crit Rev Oncol Hematol 12: 243–253
Hayes JD and Pulford DJ (1995) The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30: 445–600
Iwahana M, Utoguchi N, Mayumi T, Goryo M and Okada K (1998) Drug resistance and P-glycoprotein expression in endothelial cells of newly formed capillaries induced by tumors. Anticancer Res 18: 2977–2980
Kaplan O, Navon G, Lyon RC, Faustino PJ, Straka EJ and Cohen JS (1990) Effects of 2-deoxyglycose on drug-sensitive and drug-resistant human breast cancer cells: Toxicity and magnetic resonance spectroscopy studies of metabolism. Cancer Res 50: 544–551
Kaplan O, Jaroszewski JW, Clarke R, Fairchild CR, Schoenlein P, Goldenberg S, Gottesman MM and Cohen JS (1991) The multidrug resistance phenotype: 31P nuclear magnetic resonance characterization and 2-deoxyglucose toxicity. Cancer Res 51: 1638–1644
Kirillova GP, Mokhova EN, Dedukhova VI, Tarakanova AN, Ivanova VP, Efremova NV and Topchieva IN (1993) The influence of pluronics and their conjugates with proteins on the rate of oxygen consumption by liver mitochondria and thymus lymphocytes. Biotechnol Appl Biochem 18: 329–339
Lee JS, Paull K, Alvarez M, Hose C, Monks A, Grever M, Fojo AT and Bates SE (1994) Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen. Mol Pharmacol 46: 627–638
Mansouri A, Henle KJ and Nagle WA (1992) Multidrug resistance: prospects for clinical management. SAAS Bull Biochem Biotechnol 5: 48–52
Miller DW, Fontaine M, Kolar C and Lawson T (1996) The expression of multidrug resistance-associated protein (MRP) in pancreatic adenocarcinoma cell lines. Cancer Lett 107: 301–306
Rebbeor JF and Senior AE (1998) Effects of cardiovascular drugs on ATPase activity of P-glycoprotein in plasma mambranes and in purified reconstituted form. Biochim Biophys Acta 1369: 85–93
Shepard RL, Winter MA, Hsaio SC, Pearce HL, Beck WT and Dantzig AH (1998) Effect of Modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein. Biochem Pharmacol 56: 719–727
Slepnev VI, Kuznetsova LE, Gubin AN, Batrakova EV, Alakhov VYu and Kabanov AV (1992) Micelles of poly(oxyethylene)-poly(oxypropylene) block copolymer (pluronic) as a tool for low-molecular compound delivery into a cell. Phosphorylation of intracellular proteins with micelle incorporated [γt32P]ATP. Biochem Internat 26: 587–595
Venne A, Li S, Mandeville R, Kabanov AV and Alakhov VYu (1996) Hypersensitizing effect of Pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells. Cancer Res 56: 3626–3629
Zaman GJ, Lankelma J, van Tellingen O, Beijnen J, Dekker H, Paulusma C, Oude Elferink RP, Baas F and Borst P (1995) Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci USA 92: 7690–7694
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Batrakova, E., Li, S., Elmquist, W. et al. Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion. Br J Cancer 85, 1987–1997 (2001). https://doi.org/10.1054/bjoc.2001.2165
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.2165
Keywords
This article is cited by
-
PGMD/curcumin nanoparticles for the treatment of breast cancer
Scientific Reports (2021)
-
Effect of pluronic block polymers and N-acetylcysteine culture media additives on growth rate and fatty acid composition of six marine microalgae species
Applied Microbiology and Biotechnology (2021)
-
Recent advances of nanotechnology for the delivery of anticancer drugs for breast cancer treatment
Journal of Pharmaceutical Investigation (2020)
-
In vitro anticancer activity of folate-modified docetaxel-loaded PLGA nanoparticles against drug-sensitive and multidrug-resistant cancer cells
Cancer Nanotechnology (2019)
-
RETRACTED ARTICLE: Pluronic-based nano-self-assemblies of bacitracin A with a new mechanism of action for an efficient in vivo therapeutic effect against bacterial peritonitis
Journal of Nanobiotechnology (2018)